Brief: China Regenerative Medicine International says qtrly loss for period HK$68 mln
08/09/2017 15:09
Sept 8 (Reuters) - China Regenerative Medicine International
Ltd 8158.HK :
* Qtrly loss for period HK$68.0 million versus loss of
HK$80.5 million
* Qtrly revenue HK$71.1 million versus HK$2.7 million
Source text for Eikon: urn:newsml:reuters.com:*:nHKS7WxDWh
Further company coverage: 8158.HK
(bangalore.newsroom@thomsonreuters.com)
Recent news on China Regenerative Medicine International
See all newsBrief: China Regenerative Medicine International Expects FY Profit To Increase At Least 28%
Brief: China Regenerative Medicine International Says Yan Shibin Will Be Appointed As CFO
Brief: China Regenerative Medicine International Posts H1 Revenue Of HKD59.78 Mln
Brief: China Regenerative Medicine International Posts FY Loss Attributable HK$107.7 Mln
Brief: China Regenerative Medicine International Says Subscription Of Increased Registered Capital